Multidimensional optimization of promising antitumor xanthone derivatives

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Xanthone derivatives show promise as antitumor agents.
• Optimization of lead compounds is crucial for developing effective cancer therapeutics.

Purpose of the Study:

• To synthesize and evaluate novel xanthone analogues for antitumor activity.
• To investigate the structure-activity relationships (SAR) of these compounds.
• To develop an improved synthetic route for lead xanthone derivatives.

Main Methods:

• Multidimensional optimization including synthesis of 17 analogues.
• Evaluation of lipophilicity using partition coefficient (K(p)) with liposomes and micelles.
• Assessment of growth inhibitory activity (GI50) against four human tumor cell lines, including HL-60.

Main Results:

• A new synthetic route was established for the lead xanthone derivative and its analogues.
• Compounds exhibited logK(p) values between 3 and 5, with good correlation between liposome and micelle models.
• The most potent analogue displayed a GI50 of 5.1 μM against HL-60 cells, surpassing the original hit compound.

Conclusions:

• The study successfully optimized a xanthone derivative, yielding analogues with enhanced antitumor potential.
• Lipophilicity and solubility studies provide insights into the pharmacokinetic properties of these compounds.
• The developed synthetic route and identified potent analogues offer a foundation for further anticancer drug development.